Imberti, Jacopo Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.706
AS - Asia 6.429
EU - Europa 2.921
SA - Sud America 950
OC - Oceania 256
Continente sconosciuto - Info sul continente non disponibili 162
AF - Africa 127
Totale 17.551
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.470
SG - Singapore 2.067
CN - Cina 1.909
IT - Italia 1.024
BR - Brasile 741
HK - Hong Kong 726
VN - Vietnam 610
GB - Regno Unito 358
FI - Finlandia 305
KR - Corea 299
DE - Germania 272
BD - Bangladesh 260
AU - Australia 254
SE - Svezia 229
RU - Federazione Russa 195
FR - Francia 138
CA - Canada 112
ID - Indonesia 102
IN - India 91
AR - Argentina 78
MX - Messico 75
NL - Olanda 67
JP - Giappone 42
AE - Emirati Arabi Uniti 40
IQ - Iraq 40
TR - Turchia 40
PL - Polonia 38
ZA - Sudafrica 38
AT - Austria 35
PK - Pakistan 35
UA - Ucraina 33
BG - Bulgaria 31
CO - Colombia 31
LT - Lituania 31
ES - Italia 30
EC - Ecuador 28
UZ - Uzbekistan 22
MA - Marocco 20
VE - Venezuela 20
CL - Cile 19
EG - Egitto 18
IE - Irlanda 18
TH - Thailandia 17
KE - Kenya 16
RS - Serbia 16
MY - Malesia 14
AZ - Azerbaigian 13
BE - Belgio 13
SA - Arabia Saudita 13
CZ - Repubblica Ceca 12
RO - Romania 12
DZ - Algeria 11
PY - Paraguay 11
TW - Taiwan 11
TN - Tunisia 10
BO - Bolivia 9
JO - Giordania 9
OM - Oman 9
KZ - Kazakistan 8
PT - Portogallo 8
HU - Ungheria 7
NP - Nepal 7
PE - Perù 7
PH - Filippine 7
AL - Albania 6
CH - Svizzera 6
GE - Georgia 6
GT - Guatemala 6
JM - Giamaica 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
CR - Costa Rica 5
CU - Cuba 5
DO - Repubblica Dominicana 5
IL - Israele 5
IR - Iran 5
UY - Uruguay 5
BY - Bielorussia 4
HR - Croazia 4
SK - Slovacchia (Repubblica Slovacca) 4
CY - Cipro 3
HN - Honduras 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
NO - Norvegia 3
PS - Palestinian Territory 3
SN - Senegal 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
LB - Libano 2
MT - Malta 2
NG - Nigeria 2
Totale 17.365
Salva come PNG Salva come JPEG
Città #
Singapore 1.284
Santa Clara 999
Hefei 931
Ashburn 868
Hong Kong 718
San Jose 657
Seoul 299
Helsinki 246
Beijing 238
Fairfield 237
Chandler 220
Council Bluffs 215
London 215
Los Angeles 211
Ho Chi Minh City 198
New York 195
Nyköping 180
Perth 167
The Dalles 166
Hanoi 133
Dallas 117
Chicago 114
Milan 105
Houston 102
Woodbridge 96
Munich 91
Bologna 89
Seattle 86
Buffalo 84
Wilmington 78
Rome 74
Cambridge 72
Lauterbourg 71
São Paulo 71
Shanghai 70
Jakarta 69
Modena 55
Kent 52
Moscow 51
Salt Lake City 47
San Diego 47
Mexico City 40
Orem 40
Sydney 40
Lappeenranta 39
Boardman 38
Princeton 37
Frankfurt am Main 36
Ann Arbor 34
Tokyo 34
Da Nang 33
Montreal 32
Toronto 31
Haiphong 29
Sofia 29
Atlanta 27
Warsaw 26
Schiffdorf 25
Southend 25
Denver 24
Johannesburg 24
Amsterdam 23
Redondo Beach 23
Columbus 21
Nuremberg 21
Turin 21
Dublin 20
Memphis 20
Naples 20
Tashkent 20
Guangzhou 19
Rio de Janeiro 19
Turku 19
Vienna 19
Brooklyn 18
Parma 18
Stockholm 18
Düsseldorf 17
Phoenix 17
Baghdad 16
North Bergen 16
Portsmouth 16
San Francisco 16
Belo Horizonte 15
Campinas 15
Chennai 15
Hải Dương 15
Kilburn 15
Biên Hòa 14
Boston 14
Elk Grove Village 14
Miami 14
Tampa 14
Melbourne 13
Porto Alegre 13
Belgrade 12
Curitiba 12
Mumbai 12
Nairobi 12
Perugia 12
Totale 11.309
Salva come PNG Salva come JPEG
Nome #
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 503
Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) 321
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 304
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 303
Drug management of atrial fibrillation in light of guidelines and current evidence: an Italian Survey on behalf of Italian Association of Arrhythmology and Cardiac Pacing 288
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 280
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 275
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 258
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 257
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 252
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 239
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 224
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 221
Remote monitoring and telemedicine in heart failure: implementation and benefits 220
Progression of Atrial Fibrillation after Cryoablation 219
Atrial fibrillation burden: Stepping beyond the categorical characterization 216
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 204
What do we do about atrial high rate episodes? 203
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 203
Single-lead VDD pacing: a literature review on short-term and long-term performance 201
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 200
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 200
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 200
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 191
Clinical significance and prognostic value of right bundle branch block in permanent pacemaker patients 190
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 189
Female sex and stroke in atrial fibrillation: an intriguing relationship 189
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 187
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 187
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 182
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry 177
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 176
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 176
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 175
Atrial fibrillation in pneumonia: what clinical implications at long-term? 172
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 171
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 169
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 167
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 167
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 165
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 163
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 162
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 158
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 158
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 156
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: A systematic review and meta-analysis 156
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 156
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 154
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 153
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 148
Clinical decisions for appropriate management of patients with atrial fibrillation 146
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 146
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation 145
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 144
Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry 143
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 142
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 139
Inhibition of lysyl oxidase stimulates TGF-β signaling and metalloproteinases-2 and -9 expression and contributes to the disruption of ascending aorta in rats: protection by propylthiouracil 139
Atrial Fibrillation Ablation in Patients Recently Hospitalized for Worsening Heart Failure: Need for Individualized Decision-Making 139
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 137
Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation 136
Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe 132
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply 132
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature 129
The epidemiology and mortality of patients with atrial fibrillation: a complex landscape 128
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence 127
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate? 126
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 124
Performance of a multi-sensor implantable defibrillator algorithm for heart failure monitoring in the presence of atrial fibrillation 123
Atrial fibrillation, comorbidities, stroke, and mortality in real‑world clinical practice 123
Echocardiographic Left Ventricular Mass Assessment: Correlation between 2D-Derived Linear Dimensions and 3-Dimensional Automated, Machine Learning-Based Methods in Unselected Patients 121
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation 120
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 120
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy 117
Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry 117
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry 117
Antiarrhythmic drugs in the era of atrial fibrillation ablation 115
The challenge to improve knowledge on the interplay between subclinical atrial fibrillation, atrial cardiomyopathy, and atrial remodeling 114
Screening for atrial fibrillation: different approaches targeted to reduce ischemic stroke 112
Oral anticoagulation for atrial fibrillation and high risk of bleeding in daily practice: What clinical considerations? 112
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) Registry 110
4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients 109
The search for a gold standard to clinically diagnose and monitor atrial cardiomyopathy 109
Detection and management of postoperative atrial fibrillation after coronary artery bypass grafting or non-cardiac surgery: a survey by the AF-SCREEN International Collaboration 107
Mobile health technology in atrial fibrillation 107
Multimorbidity in atrial fibrillation: A call for integrated patient-centered care 106
Procedural complications in patients undergoing catheter ablation for atrial fibrillation: Let's talk about sex 106
The burden of atrial fibrillation in patients with preserved or mildly reduced heart failure: a call to action for detecting atrial fibrillation and improving outcome 105
Letter by Imberti et al Regarding Article, "DREAM-ICD-II Study" 104
Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: An open challenge for health care systems 103
Effectiveness of atrial fibrillation ablation in heart failure across the entire spectrum of left ventricular ejection fraction 100
Updating a simple clinical score predicting incident atrial fibrillation: The C2HEST score or more (mC2HEST)? 99
Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry 98
Access to implantable cardioverter defibrillator therapy within and across countries: the barriers still persist 96
Length of hospital stay for elective electrophysiological procedures: a survey from the European Heart Rhythm Association 95
Remote monitoring of cardiac implantable electronic devices: from data to clinical actions 95
Atrial fibrillation screening: The importance of the patient perspective 91
Real-World Use of ARNI Within GDMT in HFrEF Patients with and Without Atrial Fibrillation: A Retrospective Analysis of Cardiac and Renal Functions and Clinical Outcomes 85
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure and preserved or mildly reduced ejection fraction: closer to Ithaca after a long odyssey? 84
Validation of a multiple‑lead smartphone-based electrocardiograph with automated lead placement for layman use in patients with hypertrophic cardiomyopathy 81
Totale 16.240
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022615 0 76 14 24 25 43 18 38 68 42 126 141
2022/2023835 88 92 81 50 64 110 29 90 94 19 73 45
2023/20241.088 18 55 67 110 240 141 88 132 18 37 57 125
2024/20254.367 74 58 264 230 616 564 407 263 420 285 633 553
2025/20269.430 679 430 805 1.129 975 476 1.306 537 1.128 787 667 511
2026/2027586 516 70 0 0 0 0 0 0 0 0 0 0
Totale 17.551